Profund Advisors’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-42,652
| Closed | -$149K | – | 1137 |
|
|
2024
Q3 | $149K | Sell |
42,652
-3,876
| -8% | -$13.6K | 0.01% | 1083 |
|
|
2024
Q2 | $153K | Sell |
46,528
-65,823
| -59% | -$216K | 0.01% | 1018 |
|
|
2024
Q1 | $825K | Buy |
+112,351
| New | +$825K | 0.03% | 405 |
|
|
2023
Q3 | – | Sell |
-171,261
| Closed | -$815K | – | 1017 |
|
|
2023
Q2 | $815K | Sell |
171,261
-83,728
| -33% | -$399K | 0.04% | 371 |
|
|
2023
Q1 | $1.45M | Buy |
254,989
+243,798
| +2,179% | +$1.39M | 0.09% | 189 |
|
|
2022
Q4 | $113K | Buy |
11,191
+229
| +2% | +$2.31K | 0.01% | 961 |
|
|
2022
Q3 | $246K | Sell |
10,962
-192
| -2% | -$4.31K | 0.02% | 696 |
|
|
2022
Q2 | $276K | Sell |
11,154
-1,357
| -11% | -$33.6K | 0.02% | 692 |
|
|
2022
Q1 | $485K | Sell |
12,511
-1,400
| -10% | -$54.3K | 0.02% | 593 |
|
|
2021
Q4 | $814K | Sell |
13,911
-1,584
| -10% | -$92.7K | 0.03% | 392 |
|
|
2021
Q3 | $918K | Buy |
15,495
+13,141
| +558% | +$779K | 0.03% | 389 |
|
|
2021
Q2 | $204K | Buy |
+2,354
| New | +$204K | 0.01% | 1347 |
|